Stay updated on Effectiveness of RXI 109 on Hypertrophic Scars Clinical Trial
Sign up to get notified when there's something new on the Effectiveness of RXI 109 on Hypertrophic Scars Clinical Trial page.

Latest updates to the Effectiveness of RXI 109 on Hypertrophic Scars Clinical Trial page
- Check5 days agoChange DetectedThe clinical trial record for RXI-109 is now displayed, describing a Phase 2 study of treatment intended to reduce recurrence of hypertrophic scars after revision surgery. It includes participant criteria, study locations, outcome measures, and record dates.SummaryDifference36%

- Check12 days agoChange DetectedThe footer’s ClinicalTrials.gov revision identifier changed from v3.7.2 to v3.8.0; the study record remains inaccessible.SummaryDifference0.2%

- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedA notice about NIH website changes appears above the ClinicalTrials.gov 403 error page. The displayed site revision changes from v3.7.1 to v3.7.2.SummaryDifference1%

- Check40 days agoChange DetectedThe footer revision identifier changed from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check54 days agoChange DetectedA 403 Forbidden error page is now displayed, replacing the study record content. The header and footer remain visible with a Home link for navigation.SummaryDifference15%

- Check61 days agoChange DetectedA new site revision tag v3.7.0 was added, replacing the previous v3.6.6 tag. This appears to be a maintenance or version update that does not alter study content or visible user-facing information.SummaryDifference0.1%

Stay in the know with updates to Effectiveness of RXI 109 on Hypertrophic Scars Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Effectiveness of RXI 109 on Hypertrophic Scars Clinical Trial page.